Skip to content
Screener

Exagen Inc. XGN Q1 2026 earnings

Reported May 11, 2026 · Before market open

Revenue$17.3MBeat by $897.4K
EPS-$0.17Beat by $0.07
Revenue estimate$16.4M
EPS estimate-$0.24

Next report

Nov 3, 2026 (In 3 weeks)
Revenue estimate$18.3M
EPS estimate-$0.19

Financials

Q1 2026

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$72.16M+12.3%
Enterprise value$77.59M+1.7%
P/S1.1×-0.1×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Segments

By segment

See full
Reportable Segment$17.3M+11.7%

FAQ

When did Exagen Inc. report Q1 2026 earnings?
Exagen Inc. (XGN) reported Q1 2026 earnings on May 11, 2026 before market open.
What were Exagen Inc.'s Q1 2026 revenue and EPS?
Exagen Inc. reported revenue of $17.3M and eps of $-0.17 for Q1 2026.
Did Exagen Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $16.4M by $897.4K. EPS beat the consensus estimate of $-0.24 by $0.07.
How did Exagen Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.7% from $15.5M a year earlier and eps grew 15.0% from $-0.20.
Where can I find Exagen Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001274737-26-000027) and the 10-Q periodic report (0001274737-26-000029) directly on SEC EDGAR. The filing index links above go to sec.gov.